Restrictions for ICD patients in daily life;Was darf ein ICD-träger und was nicht?

Herz

Volumn 30, Issue 7, 2005, Pages 625-629

  Köbe, Julia ^a   Gradaus, Rainer ^a   Zumhagen, Sven ^a   Böcker, Dirk ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Driving restrictions; Electromagnetic interference; Implantable cardioverter defibrillator

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; DEFIBRILLATOR; DISEASE CLASSIFICATION; ELECTROMAGNETIC FIELD; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IONIZING RADIATION; MOBILE PHONE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; QUALITY OF LIFE;

ACCIDENTS, TRAFFIC; AUTOMOBILE DRIVING; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; GERMANY; GUIDELINES; QUALITY OF LIFE; RISK ASSESSMENT; TACHYCARDIA, VENTRICULAR;

EID: 28744434913     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-005-2747-9     Document Type: Article

References (19)

1. Baessler C, Murphy S, Gebhardt L, et al. Time to resumption of driving after implantation of an automatic defibrillator (from the DAVID trial). Am J Cardiol 2005;95:665-6.
2. Center for Devices and Radiological Health. Medical device reporting (verfügbar unter: http://www.access data.fda.gov/scripts/cdrh/cfdocs/ cfMAUDE/search. CFM).
3. Fetter JG, Benditt DG, Stantan MS. Electromagnetic interference from welding and motors on implantable cardioverter-defibrillators as tested in the electrically hostile work site. J Am Coll Cardiol 1996;28:423-7.
4. Fiek M, Dorwarth U, Durchlaub I, et al. Application of radiofrequency energy in surgical and interventional procedures: are there interactions with ICDs? Pace 2004;27:293-8.
5. Fiek M, Remp T, Reithmann C, et al. Complete loss of programmability after magnetic resonance imaging. PACE 2004;27:1002-4.
6. Finch NJ, Leman RB, Kratz JM, et al. Driving safety among patients with automatic implantable cardioverter-defibrillators. JAMA 1993;270:1587-8.
7. Gemeinsamer Beirat der Verkehrsmedizin bei den Bundesverkehrsministerien für Verkehr und Gesundheit. Gutachten Krankheit und Kraftverkehr, Fassung 2000.
8. Grimm W, Flores BT, Marchlinski FE. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy. Circulation 1993;87:1880-8.
9. Hayes JJ, Juknavorian R, Maloney JD. The role(s) of the industry employed allied professional. PACE 2001;24:398-9.
10. Hohnloser SH, Andresen D, Block M, et al. Leitlinien zur Implantation von Defibrillatoren. Z Kardiol 2000;89:126-35.
11. Jung W, Anderson M, Camm AJ, et al. Recommendations for driving of patients with implantable cardioverter defibrillators. Eur Heart J 1997;18:1210-9.
12. Kolb C, Schmieder S, Lehmann G, et al. Do airport metal detectors interfere with implantable pacemakers or cardioverter-defibrillators? J Am Coll Cardiol 2003;41:2054-9.
13. Levine JH, Mellits ED, Baumgardner RA, et al. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators. Circulation 1991;84:558-66.
14. Niehaus M, Tebbenjohanns J. Electromagnetic interference in patients with implanted pacemakers or cardioverter-defibrillators. Heart 2001;86:246-8.
15. Pinski SL, Trohman RG. Interference in implanted cardiac devices, part I. PACE 2002;25:1367-81.
16. Pinski SL, Trohman RG. Interference in implanted cardiac devices, part II. PACE 2002;25:1496-509.
17. Roguin A, Zviman MM, Meininger GR, et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation 2004;110:475-82.
18. Weber M, Block M, Brunn J, et al. Inadequate therapies with implantable cardioverter-defibrillators - incidence, etiology, predictive factors and preventive strategies. Z Kardiol 1996;11:809-19.
19. Wollmann C, Grude M, Tombach B, et al. Safe performance of magnetic resonance imaging on a patient with an ICD. PACE 2005;28:339-42.